Takeda Italia, investments of over 270 million euros in 5 years in the Rieti and Pisa plants

Takeda presented in Rome the new 2021-2025 investment plan of over 270 million euros which will mainly concern the two plants in Pisa and Rieti. Active for over 240 years in more than 80 countries, with approximately 47,000 employees worldwide and over 1,100 in Italy, the Japanese biopharmaceutical company has decided to further consolidate the production of plasma-derived drugs.